This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Analysts Estimate Navient (NAVI) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Navient (NAVI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should Ally Financial Stock be in Your Portfolio Ahead of Q3 Earnings?
by Swayta Shah
ALLY will report Q3 earnings this Friday. Amid the asset quality scare, let's decipher whether the stock is worth a look or if investors should avoid it.
Toronto Dominion Bank Faces $20M Penalty Over U.S. Market Manipulation
by Zacks Equity Research
TD agrees to pay more than $20M over spoofing charges and inadequate supervision of its U.S. Treasuries desk.
Navient Finalizes Divesture of Healthcare Services Arm to CorroHealth
by Zacks Equity Research
NAVI to divest its healthcare services business Xtend to CorroHealth. Over 925 Xtend employees join the CorroHealth team as part of the deal.
Is the Options Market Predicting a Spike in Navient (NAVI) Stock?
by Zacks Equity Research
Investors need to pay close attention to Navient (NAVI) stock based on the movements in the options market lately.
Navient Banned to Service Federal Direct Loans, To Pay $120M to CFPB
by Zacks Equity Research
The CFPB issues an order against NAVI to permanently ban it from servicing federal direct loans. Navient needs to pay $120 million to settle the CFPB's claims.
UBS Group (UBS) to Divest Quantitative Investment Strategies Unit
by Zacks Equity Research
UBS Group's (UBS) asset management unit is planning to transfer its QIS business to Manteio Partners LLC. After the completion, the QIS division is set to operate as an independent unit under Manteio.
Navient (NAVI) to Divest Healthcare Services Arm to CorroHealth
by Zacks Equity Research
Navient (NAVI) will divest its Healthcare Services business as part of an ongoing plan to streamline its business operations.
Credit Acceptance (CACC) Posts Q2 Loss, Y/Y Rise in Provisions
by Zacks Equity Research
Credit Acceptance (CACC) records a y/y rise in revenues and operating expenses in the second quarter of 2024.
LendingTree (TREE) Gains 4.4% Despite Q2 Earnings Miss Estimates
by Zacks Equity Research
A fall in EBITDA and liquidity level negatively impacts LendingTree's (TREE) Q2 earnings, while higher revenues and lower costs support its performance.
Sallie Mae's (SLM) Q2 Earnings Top Estimates, Expenses Rise
by Zacks Equity Research
Sallie Mae's (SLM) second-quarter 2024 results reflect lower provisions and robust loan origination. A decline in NII and a rise in expenses were spoilsports.
Navient (NAVI) Q2 Earnings Beat on Lower Expenses, NII Falls Y/Y
by Zacks Equity Research
Navient's (NAVI) Q2 earnings benefit from reduced expenses and a solid-liquid profile. However, lower NII and other income act as headwinds.
Compared to Estimates, Navient (NAVI) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Navient (NAVI) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Navient's (NAVI) Q2 Earnings to be Hurt by a Decline in NII
by Zacks Equity Research
Lower NII due to high interest rates and weakened consumer loan demand are likely to have hurt Navient's (NAVI) second-quarter 2024 performance.
Ally Financial (ALLY) Beats Q2 Earnings Estimates
by Zacks Equity Research
Ally Financial (ALLY) delivered earnings and revenue surprises of 56.45% and 1.08%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Navient (NAVI) Hurt by Lower Revenues & Higher Debt Level
by Zacks Equity Research
Navient (NAVI) faces challenges with regulatory changes and a year-over-year decline in servicing revenues. Also, high debt levels compared with liquidity position acts as a headwind.
Hercules Capital (HTGC) Q1 Earnings Beat Despite Higher Costs
by Zacks Equity Research
Hercules Capital (HTGC) records y/y increases in total investment income and expenses in the first quarter of 2024.
Ares Capital (ARCC) Up on Q1 Earnings Meet, Y/Y Revenue Rise
by Zacks Equity Research
Ares Capital (ARCC) records y/y increases in revenues and expenses in the first quarter of 2024.
Credit Acceptance (CACC) Q1 Earnings Miss on Higher Provisions
by Zacks Equity Research
Credit Acceptance (CACC) records a y/y rise in revenues and operating expenses in the first quarter of 2024.
LendingTree (TREE) Gains 29.2% as Q1 Earnings Beat Estimates
by Zacks Equity Research
LendingTree's (TREE) Q1 results benefit from a rise in EBITDA and a decline in costs. However, lower revenues are near-term concerns.
Capital One (COF) Q1 Earnings Miss, Provisions Decline Y/Y
by Zacks Equity Research
Capital One (COF) records y/y increases in revenues and expenses in the first quarter of 2024.
Sallie Mae's (SLM) Q1 Earnings Beat Estimates, Expenses Rise
by Zacks Equity Research
Higher non-interest expenses hurt Sallie Mae's (SLM) Q1 earnings, while a y/y rise in non-interest income and a fall in provisions offer some support.
Navient (NAVI) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
Although the revenue and EPS for Navient (NAVI) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Navient (NAVI) Q1 Earnings Beat on Lower Expenses, NII Dips
by Zacks Equity Research
A rise in the total other income and a fall in expenses aid Navient's (NAVI) first-quarter 2024 earnings.
Navient (NAVI) to Report Q1 Earnings: What to Expect?
by Zacks Equity Research
Navient's (NAVI) Q1 results are expected to reflect sequential improvements in asset recovery and business-processing revenues, and NII. Servicing revenues are likely to have been affected.